ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.

Lucia Nogova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.